Sacituzumab (powder) [CAS 1796566-95-4]

Sacituzumab (powder) is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab (powder) demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab (powder) can be used for the synthesis of antibody-drug conjugates (ADC) drug Sacituzumab govitecan. Sacituzumab govitecan can be used in the field of triple-negative breast cancer[1][2][3][4].

[1796566-95-4]

[Sacituzumab(powder)]

ADC Antibody; TROP2

98.33

Store at -80°C for 2 years

Dry Ice